Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by DOHERTY, M.
Right arrow Articles by WATT, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by DOHERTY, M.
Right arrow Articles by WATT, I.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1993 British Society for Rheumatology

research-article

PYROPHOSPHATE ARTHROPATHY: A PROSPECTIVE STUDY

M. DOHERTY, P. DIEPPE* and I. WATT{dagger}

Rheumatology Unit, City Hospital Nottingham
*Department of Rheumatology Bristol
{dagger}Radiology, Bristol Royal Infirmary Birstol

Correspondence to: Correspondence to Dr M. Doherty, Rheumatology Unit, City Hospital, Nottingham NG5 1PB

One hundred and four consecutive patients with pyrophosphate arthropathy were followed prospectively and re-studied at a mean of 4.6 years. Sixty-four patients (43F, 21M; mean age at review 71.2 years) completed the study (24 died of unrelated disease, 16 were unavailable for review). The knee had been the major presenting joint in 91%. Symptoms were improved in 41%, unchanged in 33% and had worsened in only 27%: 27% developed symptoms in new joints. Radiographic changes of arthropathy were unaltered in 50%: although ‘worsening’ of previously involved joints was seen in 16%, the most common change was increase in osteophyte with bone remodelling (31%). Despite dynamic changes in chondrocalcinosis in most patients (77%) there was no correlation between extent of calcification and progression of arthropathy. It is concluded that the outcome of pyrophosphate arthropathy is not necessarily progressive, patients presenting with acute attacks alone do particularly well.

KEY WORDS: Calcium pyrophosphate, Osteoarthritis, Crystals


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Rheumatology (Oxford)Home page
P. Richette, T. Bardin, and M. Doherty
An update on the epidemiology of calcium pyrophosphate dihydrate crystal deposition disease
Rheumatology, July 1, 2009; 48(7): 711 - 715.
[Abstract] [Full Text] [PDF]

Home page
 Ann Rheum DisHome page
G. Filippou, B. Frediani, A. Gallo, L. Menza, P. Falsetti, F. Baldi, C. Acciai, S. Lorenzini, M. Galeazzi, and R. Marcolongo
A "new" technique for the diagnosis of chondrocalcinosis of the knee: sensitivity and specificity of high-frequency ultrasonography
Ann Rheum Dis, August 1, 2007; 66(8): 1126 - 1128.
[Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
S. Rajakulendran, D. Smith, and C. Deighton
Re: Aouba et al. Crowned dens syndrome misdiagnosed as polymyalgia rheumatica, giant cell arteritis, meningitis or spondylitis
Rheumatology, March 1, 2006; 45(3): 360 - 361.
[Full Text] [PDF]

Home page
 Ann Rheum DisHome page
R L Neame, A J Carr, K Muir, and M Doherty
UK community prevalence of knee chondrocalcinosis: evidence that correlation with osteoarthritis is through a shared association with osteophyte
Ann Rheum Dis, June 1, 2003; 62(6): 513 - 518.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.